Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tetraphase Pharmaceu (TTPH)

Tetraphase Pharmaceu (TTPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tetraphase Pharmaceu 480 ARSENAL WAY WATERTOWN MA 02472 USA

www.tphase.com P: 617-715-3600

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Tetraphase Pharmaceuticals, Inc. is a life science company engaged in developing and commercializing tetracycline based drugs to treat drug-resistant infectious diseases, inflammation, and cancer. Its principal products include eravacycline, an intravenous and oral antibiotic for the treatment of multi-drug resistant Gram-negative infections. The Company's product under development includes eravacycline oral formulation, TP-834 and TP-271. Tetraphase Pharmaceuticals, Inc. is based in Watertown, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 15,979
Shares Outstanding, K 7,263
Float, K 6,849
% Float 94.30%
% of Insider Shareholders 5.70%
% of Institutional Shareholders 42.29%

Financials:

Annual Sales, $ 7,380 K
Annual Net Income, $ -70,090 K
Last Quarter Sales, $ 1,760 K
Last Quarter Net Income, $ -12,120 K

Growth:

1-Year Return -68.99%
3-Year Return -98.05%
5-Year Return -99.74%
5-Year Revenue Growth -18.90%
5-Year Earnings Growth 54.12%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/13/20
Earnings Per Share ttm -18.46
EPS Growth vs. Prev Qtr 52.36%
EPS Growth vs. Prev Year 81.81%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 09/27/19

TTPH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -210.86%
Return-on-Assets % -121.73%
Profit Margin % -949.73%
Debt/Equity 0.06
Price/Sales 2.25
Price/Cash Flow N/A
Price/Book 0.58
Book Value/Share 3.78
Interest Coverage -26.17
60-Month Beta 2.33
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar